V

Vistin Pharma ASA
OSE:VISTN

Watchlist Manager
Vistin Pharma ASA
OSE:VISTN
Watchlist
Price: 23.4 NOK
Market Cap: 1B NOK
Have any thoughts about
Vistin Pharma ASA?
Write Note

Vistin Pharma ASA
Investor Relations

Vistin Pharma ASA engages in the manufacture and sale of metformin products. The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The company was created as a result of spin-off of Weifa AS. The company specializes in manufacture of Active Pharmaceutical Ingredients (API) and Solid Dosage Forms. Its products portfolio is comprised of Metformin, Pholcodine and Codeine Phosphate, among others. The firm's products are sold domestically and abroad, including markets in Asia, America, Africa and Europe.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Magnus Tolleshaug
CEO, Chief Commercial Officer & Commercial Director
No Bio Available
Mr. Alexander Karlsen
Chief Financial Officer
No Bio Available
Mr. Vegard Heggem
Chief Operating Officer
No Bio Available
Eivind Egeli
Director of Technical Service & Sales
No Bio Available

Contacts

Address
OSLO
Oslo
Ostensjoveien 27
Contacts
+4735984200.0